Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up

Trigger point injections for low back pain relief

Official title: Trigger Point Injection for Myofascial Pain Syndrome in the Low Back (T-PIMPS): A Randomized Controlled Trial.

Run by Madigan Army Medical Center · NCT04704297 · Data updated 2026-11-12

This study is testing whether trigger point injections can help people with lower back pain feel better and improve their ability to move after visiting the Emergency Department.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment180 (estimated)
SponsorMadigan Army Medical Center
Federal
Locations1 site (Tacoma, Washington)
StatusRecruiting
StartedDecember 28, 2020
Main results expectedJuly 1, 2022
Study endsJuly 1, 2022
Registry record updatedJanuary 12, 2021
Trial IDNCT04704297 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who have at least one trigger point in their low back paraspinal muscles and are experiencing exacerbations of chronic low back pain.

Probably not a fit

Patients with conditions such as fibromyalgia, rheumatoid arthritis, or those who have had recent spinal surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of trigger point injections (TPI) in treating myofascial pain syndrome in the lower back, particularly in patients presenting to the Emergency Department. The study aims to address the limitations of previous research by employing a randomized controlled design and focusing on patient-centered functional outcomes. Participants will be evaluated for pain relief and functional ability using the Modified Oswestry Disability Index, with follow-up assessments conducted 60-72 hours post-treatment. The trial seeks to provide clearer insights into the efficacy of TPI for low back pain management.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce low back pain and improve functional outcomes for patients suffering from myofascial pain syndrome.

How similar studies have gone: Previous studies on trigger point injections have shown mixed results, indicating a need for further investigation, making this approach both relevant and necessary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years
2. Must have at least 1 trigger point in low back paraspinal muscles.
3. For exacerbations of chronic low back pain, the pain on presentation must be 1.5 cm above baseline pain on VAS

Exclusion Criteria:

1. Allergy or inability to take study medications.
2. New focal neurologic deficit in lower extremities.
3. Known active malignancy with bony spinal metastases.
4. Identifiable spinal, lumbosacral or hip fracture.
5. History of Fibromyalgia, rheumatoid arthritis, ankylosing spondylitis.
6. Current use of anticoagulation.
7. Overlying cellulitis.
8. Spinal, hip, or pelvic surgery within the past 6 months.
9. Previous administration of trigger point injections for current episode.
10. Sciatica-extending down the back of the leg to the heel.
11. Alternate identifiable cause of participant's acute pain other than myofascial or musculoskeletal pain.
12. Febrile patients.
13. Pregnant
14. Unable to understand English or otherwise unable to provide informed consent (mental handicap, inability to understand instructions, risks, or benefits), or is an at risk population (wounded warrior, resident physicians, prisoners, cadets, midshipmen, or students).

Where it's running

  • Department of Emergency Medicine, Madigan Army Medical Center
    Tacoma, Washington, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.